Fig. 5

Correlation analysis of clinical, genomic, and transcriptomic features in the PTMETA cohort. (a – e) Correlation between molecular and clinical features in the PTMETA cohort. Only correlations with significant (p < 0.10) differences calculated by Wilcoxon rank-sum tests or Fisher’s exact tests are shown; (f) Phenotypes of transcriptomic subgroups. The top rows indicate the cluster assignment of patients. The following rows show the clinical, immune features, alterations, fusion genes, number of drivers, TMB, copy number gains, copy number losses, and mutation signatures, respectively; (g –h) Genomic features of transcriptomic subgroups. Only correlations with significant (p < 0.10) differences calculated by Wilcoxon rank-sum tests or Fisher’s exact tests are shown. PTMC-Pro: PTMC-proliferation; PTMC-Inf: PTMC-inflammatory